I think this will settle at 10c in a few days and then it will be a slow grind back to 20c with the other clinical trial results. Interestingly, it has dropped more than the 1st failed US clinical trial but in a much better position, possibly as most of the SI are dumping those shares.
- Forums
- ASX - By Stock
- RAP
- Ann: Update on US FDA De Novo Classification Request
Ann: Update on US FDA De Novo Classification Request, page-64
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online